A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED,

Project: Research project

Project Details

Description

A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF MONGERSEN (GED-0301) FOR THE TREATMENT OF SUBJECTS WITH ACTIVE CROHN'S DISEASE
StatusFinished
Effective start/end date10/21/152/15/19

Funding

  • Celgene Corporation

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.